ClinicalTrials.gov record
Not listed Phase 2 Interventional

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

ClinicalTrials.gov ID: NCT02576561

Public ClinicalTrials.gov record NCT02576561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL

Study identification

NCT ID
NCT02576561
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
THEVAX Genetics Vaccine
Industry
Enrollment
10 participants

Conditions and interventions

Interventions

  • GPI-0100 Biological
  • Placebo Biological
  • TVGV-1 Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2015
Primary completion
Apr 30, 2018
Completion
Aug 31, 2018
Last update posted
Oct 24, 2017

2015 – 2018

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Visions Clinical Research - Tucson Tucson Arizona 85712
Red Rocks OBGYN Lakewood Colorado 80228
Progressive Medical Research Port Orange Florida 32127
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409
Grady Memorial Hospital Atlanta Georgia 30303
ProHEALTH Care Associates LLP Port Jefferson New York 11777
Unified Women's Clinical Research Raleigh North Carolina 27607
Unified Women's Clinical Research Winston-Salem North Carolina 27103
Complete Healthcare for Women Columbus Ohio 43231
Penn Fertility Care/Reproductive Research Unit Univ of Pennsylvania Philadelphia Pennsylvania 19104
Insearch-Tidewater Clinical Research Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02576561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2017 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02576561 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →